219 related articles for article (PubMed ID: 9384340)
21. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
[TBL] [Abstract][Full Text] [Related]
22. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.
Yeh SH; Zangwill KM; Lee H; Chang SJ; Wong VI; Greenberg DP; Ward JI
Vaccine; 2003 Jun; 21(19-20):2627-31. PubMed ID: 12744899
[TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.
Mbelle N; Huebner RE; Wasas AD; Kimura A; Chang I; Klugman KP
J Infect Dis; 1999 Oct; 180(4):1171-6. PubMed ID: 10479145
[TBL] [Abstract][Full Text] [Related]
24. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
[TBL] [Abstract][Full Text] [Related]
25. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
[TBL] [Abstract][Full Text] [Related]
27. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
Dagan R; Givon-Lavi N; Porat N; Greenberg D
Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
[TBL] [Abstract][Full Text] [Related]
28. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M
Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412
[TBL] [Abstract][Full Text] [Related]
29. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
Nieminen T; Käyhty H; Leroy O; Eskola J
Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
[TBL] [Abstract][Full Text] [Related]
30. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants.
Obaro SK; Adegbola RA; Chang I; Banya WA; Jaffar S; Mcadam KW; Greenwood BM
Pediatr Infect Dis J; 2000 May; 19(5):463-9. PubMed ID: 10819345
[TBL] [Abstract][Full Text] [Related]
31. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
[TBL] [Abstract][Full Text] [Related]
32. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
33. A cross-sectional survey of the prevalence of Streptococcus pneumoniae nasopharyngeal carriage in Belgian infants attending day care centres.
Malfroot A; Verhaegen J; Dubru JM; Van Kerschaver E; Leyman S
Clin Microbiol Infect; 2004 Sep; 10(9):797-803. PubMed ID: 15355410
[TBL] [Abstract][Full Text] [Related]
34. Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
Olander RM; Wuorimaa T; Käyhty H; Leroy O; Dagan R; Eskola J
Vaccine; 2001 Nov; 20(3-4):336-41. PubMed ID: 11672895
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study.
Carmona Martinez A; Prymula R; Miranda Valdivieso M; Otero Reigada MDC; Merino Arribas JM; Brzostek J; Szenborn L; Ruzkova R; Horn MR; Jackowska T; Centeno-Malfaz F; Traskine M; Dobbelaere K; Borys D
Vaccine; 2019 Jan; 37(1):176-186. PubMed ID: 30054160
[TBL] [Abstract][Full Text] [Related]
36. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
[TBL] [Abstract][Full Text] [Related]
37. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants.
Puumalainen T; Dagan R; Wuorimaa T; Zeta-Capeding R; Lucero M; Ollgren J; Käyhty H; Nohynek H
Pediatr Infect Dis J; 2003 Feb; 22(2):141-9. PubMed ID: 12586978
[TBL] [Abstract][Full Text] [Related]
38. Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.
Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gruber WC; Scott DA
Vaccine; 2016 Aug; 34(36):4313-20. PubMed ID: 27422342
[TBL] [Abstract][Full Text] [Related]
39. Serum serotype-specific pneumococcal anticapsular immunoglobulin g concentrations after immunization with a 9-valent conjugate pneumococcal vaccine correlate with nasopharyngeal acquisition of pneumococcus.
Dagan R; Givon-Lavi N; Fraser D; Lipsitch M; Siber GR; Kohberger R
J Infect Dis; 2005 Aug; 192(3):367-76. PubMed ID: 15995949
[TBL] [Abstract][Full Text] [Related]
40. Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial.
Lucero MG; Puumalainen T; Ugpo JM; Williams G; Käyhty H; Nohynek H
J Infect Dis; 2004 Jun; 189(11):2077-84. PubMed ID: 15143476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
